Not all individuals with CLL demand therapy. Irrespective of all new innovations, the iwCLL still recommends watchful observation for patients with asymptomatic disease.86 This recommendation is based on a minimum of two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR)… Read More